BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9130265)

  • 1. Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.
    Farooqui AA; Rapoport SI; Horrocks LA
    Neurochem Res; 1997 Apr; 22(4):523-7. PubMed ID: 9130265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue.
    Farooqui AA; Horrocks LA
    J Mol Neurosci; 2001; 16(2-3):263-72; discussion 279-84. PubMed ID: 11478381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakdown of membrane phospholipids in Alzheimer disease. Involvement of excitatory amino acid receptors.
    Farooqui AA; Wells K; Horrocks LA
    Mol Chem Neuropathol; 1995; 25(2-3):155-73. PubMed ID: 8534318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmalogen-selective phospholipase A2 and its involvement in Alzheimer's disease.
    Farooqui AA; Horrocks LA
    Biochem Soc Trans; 1998 May; 26(2):243-6. PubMed ID: 9649755
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia.
    Farooqui AA; Horrocks LA
    Neuroscientist; 2001 Jun; 7(3):232-45. PubMed ID: 11499402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmalogen-selective phospholipase A2 and its role in signal transduction.
    Yang HC; Farooqui AA; Horrocks LA
    J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):9-13. PubMed ID: 8906539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity.
    Ross BM; Moszczynska A; Erlich J; Kish SJ
    J Neurochem; 1998 Feb; 70(2):786-93. PubMed ID: 9453575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide.
    Latorre E; Collado MP; Fernández I; Aragonés MD; Catalán RE
    Eur J Biochem; 2003 Jan; 270(1):36-46. PubMed ID: 12492473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective hydrolysis of plasmalogen phospholipids by Ca2+-independent PLA2 in hypoxic ventricular myocytes.
    McHowat J; Liu S; Creer MH
    Am J Physiol; 1998 Jun; 274(6):C1727-37. PubMed ID: 9611139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-independent phospholipase A2-catalyzed plasmalogen hydrolysis in hypoxic human coronary artery endothelial cells.
    Meyer MC; McHowat J
    Am J Physiol Cell Physiol; 2007 Jan; 292(1):C251-8. PubMed ID: 16943248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A frontal variant of Alzheimer's disease exhibits decreased calcium-independent phospholipase A2 activity in the prefrontal cortex.
    Talbot K; Young RA; Jolly-Tornetta C; Lee VM; Trojanowski JQ; Wolf BA
    Neurochem Int; 2000 Jul; 37(1):17-31. PubMed ID: 10781842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry.
    Han X; Holtzman DM; McKeel DW
    J Neurochem; 2001 May; 77(4):1168-80. PubMed ID: 11359882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Plasmalogen Content Does Not Influence Arachidonic Acid Levels or Distribution in Macrophages: A Role for Cytosolic Phospholipase A
    Lebrero P; Astudillo AM; Rubio JM; Fernández-Caballero L; Kokotos G; Balboa MA; Balsinde J
    Cells; 2019 Jul; 8(8):. PubMed ID: 31370188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural membrane phospholipids in Alzheimer disease.
    Wells K; Farooqui AA; Liss L; Horrocks LA
    Neurochem Res; 1995 Nov; 20(11):1329-33. PubMed ID: 8786819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane phospholipids and plasmalogens in the ischemic myocardium.
    Kako KJ
    Can J Cardiol; 1986; 2(3):184-94. PubMed ID: 2424580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane phospholipid metabolism during myocardial ischaemia: past, present and future.
    Sen A; Buja LM; Willerson JT; Chien KR
    Basic Res Cardiol; 1987; 82 Suppl 1():121-5. PubMed ID: 3311000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of plasmalogen-selective phospholipase A2 from bovine brain.
    Yang HC; Farooqui AA; Horrocks LA
    Adv Exp Med Biol; 1996; 416():309-13. PubMed ID: 9131165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homeostasis of phospholipids - The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens.
    Dorninger F; Brodde A; Braverman NE; Moser AB; Just WW; Forss-Petter S; Brügger B; Berger J
    Biochim Biophys Acta; 2015 Feb; 1851(2):117-28. PubMed ID: 25463479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.
    Diez E; Chilton FH; Stroup G; Mayer RJ; Winkler JD; Fonteh AN
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipid composition modifications influence phospholipase A2 activity in rat liver plasma membranes.
    Momchilova AB; Petkova DH; Koumanov KS
    Int J Biochem; 1986; 18(10):945-52. PubMed ID: 3792613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.